Reactions Weekly

, Volume 1636, Issue 1, pp 309–309 | Cite as

Vedolizumab

Intra-abdominal abscess: case report
Case report
  • 26 Downloads

Reference

  1. Stallmach A, et al. Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study. Alimentary Pharmacology and Therapeutics 44: 1199-1212, No. 11-12, Dec 2016. Available from: URL: http://doi.org/10.1111/apt.13813 - UnknownCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations